Updated: 25-Mar-26 09:09 ET
Ends: 24-Mar-26 | Co: GENB
Generate Biomedicines (Nasdaq) | Clinical-stage biotech using AI to design novel protein therapeutics, with multiple drug candidates in human trials | Opened: 27-Feb-26, $15.00 | Priced: $16.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley, Piper Sandler |
Ends: 31-Mar-26 | Co: MMED
MiniMed (Nasdaq) | Global diabetes technology company providing integrated insulin delivery and glucose monitoring solutions in more than 80 countries | Opened: 06-Mar-26, $19.05 | Priced: $20.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, BofA Securities, Citigroup and Morgan Stanley |
Ends: 06-Apr-26 | Co: PAYP
PayPay (Nasdaq) | Digital wallet platform, enabling QR code–based payments and financial services through its proprietary app | Opened: 12-Mar-26, $19.00 | Priced: $16.00 | Underwriters: Lead: Goldman Sachs, JP Morgan, Mizuho, and Morgan Stanley |
Ends: 14-Apr-26 | Co: JAN
Janus Living (NYSE) | U.S. REIT that owns and operates 34 senior housing communities under RIDEA structures, making it the only publicly traded REIT focused exclusively on senior housing | Opened: 20-Mar-26, 23.50 | Priced: $20.00 | Underwriters: Lead: BofA Securities, J.P. Morgan |